Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A.

about

Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A.

Item

http://www.wikidata.org/entity/Q45875327

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Break-through bleeding in rela ...... nts with severe haemophilia A.

@en

Break-through bleeding in rela ...... nts with severe haemophilia A.

@nl

type

Item

label

Break-through bleeding in rela ...... nts with severe haemophilia A.

@en

Break-through bleeding in rela ...... nts with severe haemophilia A.

@nl

prefLabel

Break-through bleeding in rela ...... nts with severe haemophilia A.

@en

Break-through bleeding in rela ...... nts with severe haemophilia A.

@nl

P1476

Break-through bleeding in rela ...... nts with severe haemophilia A.

@en

P2093

L Zhao

http://www.w3.org/2001/XMLSchema#string

N Zhang

http://www.w3.org/2001/XMLSchema#string

R Wu

http://www.w3.org/2001/XMLSchema#string

X Wang

http://www.w3.org/2001/XMLSchema#string

Y Zhen

http://www.w3.org/2001/XMLSchema#string

P2860

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS.

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective.

Considerations in individualizing prophylaxis in patients with haemophilia A.

Individualizing prophylaxis in hemophilia: a review.

Half-life extended factor VIII for the treatment of hemophilia A.

Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.

Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients.

Clinical outcomes and resource utilization associated with haemophilia care in Europe.

P304

120-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.13373

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zhenping Chen

Xiaoling Cheng

P Li

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194866

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia A

Coagulation factor VIII